Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Hepatitis C virus research, and Hepatocellular Carcinoma Treatment and Prognosis.
Predicting the Risk of Decompensation in Patients With Cirrhosis: A Validated Machine Learning Approach.
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study.
Liver Health: An Emerging Concept.
Implementation of a liver health check in people with type 2 diabetes.
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
The EASL-Lancet Commission on liver health in Europe: prevention, case-finding, and early diagnosis to reduce liver-related mortality.
Interpreting elevated liver blood test results through a genetic lens: A genome-wide association study.
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Implementation of a liver health check in people with type 2 diabetes
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease.
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease.
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease.
Time to focus on chronic liver diseases in the community: A review of primary care hepatology tools, pathways of care and reimbursement mechanisms.
Comparing magnetic resonance liver fat fraction measurements with histology in fibrosis: the difference between proton density fat fraction and tissue mass fat fraction.
Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
Reply to: "Prediction of liver-related mortality in a community setting".
SteatoSITE: an Integrated Gene-to-Outcome Data Commons for Precision Medicine Research in NAFLD
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population.
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
Performance of routine risk scores for predicting cirrhosis-related morbidity in the community.
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity.
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.